Applicant, as named in the Orange Book

Lexicon Pharms Inc

Next listed expiry: Inpefa on 7 Oct 2030. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Inpefa · 2 strengths sotagliflozin	sotagliflozin	216203	7 Oct 2030	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.